2
INVITED COMMENTARY Circadian Disruptiona New Direction for Psycho-oncology Research? A Comment on Dedert et al. Laura S. Porter, PhD Published online: 15 May 2012 # The Society of Behavioral Medicine 2012 The development of biobehavioral models of cancer has led to increasingly sophisticated studies regarding the role of psychological factors in the onset and progression of cancer. The present study by Dedert and colleagues [1], guided by a model of circadian effects of cancer progression [2], exam- ined associations between psychological responses and dis- ruptions in circadian rest/activity and cortisol rhythms in women newly diagnosed with cancer. Circadian disruptions have been linked to poorer quality of life as well as early mortality in patients with metastatic cancer [35] but have not been widely studied in nonmetastatic populations. Findings from this study indicated that women who reported more intrusive thoughts and avoidant coping dis- played circadian disruptions including daytime inactivity and inconsistent activity patterns. In addition, those with more disruptions in their activity/rest cycles had flattened diurnal cortisol rhythms. However, psychological variables were not related to cortisol disruptions (a finding consistent with several prior studies [68]). Given the small sample size and cross-sectional design of this study, these findings should be considered preliminary. However, they do suggest the possibility that psychological responses at the time of cancer diagnosis are associated with disruptions in circadian rhythms, which could influence disease progression. The methodology used to collect saliva samples and verify their timing is a particular strength of this study and should serve as a model for future research. Collection of salivary cortisol took place four times per day to capture both cortisol response to wakening and the diurnal slope. Importantly, the timing of the samples was verified using electronic MEMS caps, and bedtime and wake times were corroborated using actigraphy data. The close attention to the timing of the samples is critical; prior research indicates that noncompliance with sample collection times has a significant effect on cortisol diurnal rhythms and response to wakening [9]. Another notable strength of this study is the diversity of the participants. Two thirds of the participants were recruited from a cancer center that primarily serves low- income patients, and over one third of the participants were African-American. In contrast, the majority of previous studies examining cortisol in cancer patients have been conducted with samples consisting of predominantly Cau- casian subjects [6, 7, 10, 11]. In a recent study, we found that African-American cancer survivors had significantly flatter diurnal slopes than Caucasians [12]. Studies of com- munity samples have also found that cortisol levels and diurnal slopes differ by race and SES (e.g., [13]). Further- more, in the current study, women with lower income reported higher levels of intrusive thoughts and avoidant coping and greater rest/activity disruption. Taken together, these findings indicate the importance of including econom- ically and racially diverse samples. As noted above, the findings of this study are preliminary. However, they are intriguing and suggest several avenues for future research. First, it is plausible that there are bidirectional relationships between psychological responses to cancer and activity/rest rhythms. Longitudinal studies that measure both constructs over multiple phases of cancer survivorship (e.g., diagnosis, active treatment, survivorship, recurrence) could elucidate the nature of these associations and provide insight regarding the optimal timing and content of interventions to facilitate positive adaptation. Second, longitudinal studies are necessary to answer the critical question regarding the role of circadian disruption in disease progression. Third, if proven L. S. Porter (*) Duke University Medical Center, Box 90399, Durham, NC 27708, USA e-mail: [email protected] ann. behav. med. (2012) 44:12 DOI 10.1007/s12160-012-9376-3

Circadian Disruption—a New Direction for Psycho-oncology Research? A Comment on Dedert et al

  • Upload
    laura-s

  • View
    213

  • Download
    0

Embed Size (px)

Citation preview

INVITED COMMENTARY

Circadian Disruption—a New Direction for Psycho-oncologyResearch? A Comment on Dedert et al.

Laura S. Porter, PhD

Published online: 15 May 2012# The Society of Behavioral Medicine 2012

The development of biobehavioral models of cancer has ledto increasingly sophisticated studies regarding the role ofpsychological factors in the onset and progression of cancer.The present study by Dedert and colleagues [1], guided by amodel of circadian effects of cancer progression [2], exam-ined associations between psychological responses and dis-ruptions in circadian rest/activity and cortisol rhythms inwomen newly diagnosed with cancer. Circadian disruptionshave been linked to poorer quality of life as well as earlymortality in patients with metastatic cancer [3–5] but havenot been widely studied in nonmetastatic populations.

Findings from this study indicated that women whoreported more intrusive thoughts and avoidant coping dis-played circadian disruptions including daytime inactivityand inconsistent activity patterns. In addition, those withmore disruptions in their activity/rest cycles had flatteneddiurnal cortisol rhythms. However, psychological variableswere not related to cortisol disruptions (a finding consistentwith several prior studies [6–8]). Given the small samplesize and cross-sectional design of this study, these findingsshould be considered preliminary. However, they do suggestthe possibility that psychological responses at the time ofcancer diagnosis are associated with disruptions in circadianrhythms, which could influence disease progression.

The methodology used to collect saliva samples andverify their timing is a particular strength of this study andshould serve as a model for future research. Collection ofsalivary cortisol took place four times per day to captureboth cortisol response to wakening and the diurnal slope.Importantly, the timing of the samples was verified using

electronic MEMS caps, and bedtime and wake times werecorroborated using actigraphy data. The close attention tothe timing of the samples is critical; prior research indicatesthat noncompliance with sample collection times has asignificant effect on cortisol diurnal rhythms and responseto wakening [9].

Another notable strength of this study is the diversity ofthe participants. Two thirds of the participants wererecruited from a cancer center that primarily serves low-income patients, and over one third of the participants wereAfrican-American. In contrast, the majority of previousstudies examining cortisol in cancer patients have beenconducted with samples consisting of predominantly Cau-casian subjects [6, 7, 10, 11]. In a recent study, we foundthat African-American cancer survivors had significantlyflatter diurnal slopes than Caucasians [12]. Studies of com-munity samples have also found that cortisol levels anddiurnal slopes differ by race and SES (e.g., [13]). Further-more, in the current study, women with lower incomereported higher levels of intrusive thoughts and avoidantcoping and greater rest/activity disruption. Taken together,these findings indicate the importance of including econom-ically and racially diverse samples.

As noted above, the findings of this study are preliminary.However, they are intriguing and suggest several avenues forfuture research. First, it is plausible that there are bidirectionalrelationships between psychological responses to cancer andactivity/rest rhythms. Longitudinal studies that measure bothconstructs over multiple phases of cancer survivorship (e.g.,diagnosis, active treatment, survivorship, recurrence) couldelucidate the nature of these associations and provide insightregarding the optimal timing and content of interventions tofacilitate positive adaptation. Second, longitudinal studies arenecessary to answer the critical question regarding the role ofcircadian disruption in disease progression. Third, if proven

L. S. Porter (*)Duke University Medical Center,Box 90399, Durham, NC 27708, USAe-mail: [email protected]

ann. behav. med. (2012) 44:1–2DOI 10.1007/s12160-012-9376-3

robust, these findings suggest that interventions should spe-cifically target activity/rest disruptions. Possibilities includechronobiotics such as melatonin [14], cognitive-behavioralinterventions for insomnia [15], and exercise therapy [16].Components of psychosocial interventions for stress manage-ment could also be adapted to target circadian rhythm regula-tion. For example, social support strategies could focus on therole of friends and family in encouraging regular activity, andrelaxation training could emphasize its benefits on sleep.

Conflict of Interest Statement The author has no conflict of interestto disclose.

References

1. Dedert E, Lush E, Chagpar A, et al. Stress, coping and circadiandisruption among women awaiting breast cancer surgery. AnnBehav Med. 2012; doi: 10.1007/s12160-012-9352-y

2. Eismann EA, Lush E, Sephton SE. Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways. Psycho-neuroendocrinology. 2010;35(7):963–976.

3. Mormont M, Waterhouse J, Bleuzen P et al. Marked 24-hour rest/activity rhythms are associated with better health-related quality oflife, better response, and longer survival in patients with metastaticcolorectal cancer and good performance status. Clinical CancerResearch. 2000;6:3038–3045.

4. Innominato PF, Focan C, Gorlia T, et al. Circadian rhythm in restand activity: A biological correlate of quality of life and a predictorof survival in patients with metastatic colorectal cancer. CancerRes. 2009;69:4700–4707.

5. Sephton S, Sapolsky R, Kraemer H, Spiegel D. Diurnal cortisolrhythm as a predictor of breast cancer survival. J National CancerInstitute. 2000;92:994–1000.

6. Porter LS,MishelM, Neelon V, BelyeaM, Pisano E, SooMS. Cortisollevels and responses to mammography screening in breast cancersurvivors: A pilot study. Psychosom Med. 2003;65(5):842–848.

7. Carlson LE, Campbell TS, Garland SN, Grossman P. Associationsbetween salivary cortisol, melatonin, catecholamines, sleep quali-ty, and stress in women with breast cancer and healthy controls. JBehav Med. 2007;30(1):45–58.

8. Vedhara K, Tuinstra J, Miles JN, Sanderman R, Ranchor AV.Psychosocial factors associated with indices of cortisol productionin women with breast cancer and controls. Psychoneuroendocri-nology. 2006;31(3):299–311.

9. Kudielka BM, Broderick JE, Kirschbaum C. Compliance withsaliva sampling protocols: Electronic monitoring reveals invalidcortisol daytime profiles in noncompliant subjects. PsychosomMed. 2003;65(2):313–319.

10. Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL.Diurnal cortisol rhythm and fatigue in breast cancer survivors.Psychoneuroendocrinology. 2005;30(1):92–100.

11. Bower JE, Ganz PA, Aziz N. Altered cortisol response to psycho-logic stress in breast cancer survivors with persistent fatigue.Psychosom Med. 2005;67(2):277–280.

12. Porter LS, Mishel M, Germino B, et al. Cortisol in Caucasian andAfrican American younger breast cancer survivors: Preliminaryfindings from a psycho-educational intervention study. Poster pre-sented at the 31st Annual Meeting of the Society of BehavioralMedicine, Seattle, WA, April 7, 2010.

13. Hajat A, Diez-Roux A, Franklin TG et al. Socioeconomic and race/ethnic differences in daily salivary cortisol profiles: The multi-ethnic study of atherosclerosis. Psychoneuroendocrinology.2010;35(6):932–943.

14. Mormont M, Waterhouse J. Contribution of the rest-activity circa-dian rhythm to quality of life in cancer patients. ChronobiologyInternational. 2002;19(1):313–323.

15. Savard J, Simard S, Ivers H, Morin CM. Randomized study on theefficacy of cognitive-behavioral therapy for insomnia secondary tobreast cancer, part I: Sleep and psychological effects. J Clin Oncol.2005;23(25):6083–6096.

16. Jones LW, Peppercorn J, Scott JM, Battaglini C. Exercise therapyin the management of solid tumors. Curr Treat Options Oncol.2010;11(1–2):45–58.

2 ann. behav. med. (2012) 44:1–2